Different insulin antibody formation in diabetic patients treated with crystallized or highly purified insulins is a transient phenomenon.
Keilacker
H
H
Zentralinstitute für Diabetes Gerhardt Katsch, Karlsburg, German Democratic Republic.
Rjasanowski
I
I
Woltanski
K P
KP
Kohnert
K D
KD
Ziegler
M
M
Michaelis
D
D
D000293:Adolescent; D000915:Antibody Affinity; D000917:Antibody Formation; D002648:Child; D002675:Child, Preschool; D003460:Crystallization; D003920:Diabetes Mellitus / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007330:Insulin Antibodies / Q000276:immunology*; D008297:Male
D007330:Insulin Antibodies